I would first obtain a detailed patient history, blood work, echocardiogram, and medication reconciliation to identify more common causes of palpitations/arrhythmias. Additionally, making some lifestyle changes may be helpful in this situation
Phase 2 Initiation Targeted for Second Half of 2025 Overview of key poster abstracts Hanmi will present at ADA 2025 (Source: Hanmi Pharmaceutical homepage) (June 10, 2025) Hanmi Pharmaceutical is set to unveil a series of breakthrough research results on its next-generation, game-changing obesity drug candidates that overcome the inherent limitations of GLP-1-based therapies, including inevitable muscle loss, at one of the worlds most prestigious metabolic disease conferences
Hoy es considerado uno de los compuestos ms buscados por atletas, fisicoculturistas, personas con lesiones crnicas y quienes desean optimizar su recuperacin
Antioxidants in Greek virgin olive oils
By addressing these aspects of glucose metabolism, GLP-1 agonists have become crucial tools in managing type 2 diabetes and, more recently, obesity